ethyl 4-amino-1,1-dioxothiane-4-carboxylate
|
- $45 - $1058
- Product name: ethyl 4-amino-1,1-dioxothiane-4-carboxylate
- CAS: 1250287-78-5
- MF: C8H15NO4S
- MW: 221.27
- EINECS:
- MDL Number:MFCD16040232
- Synonyms:ethyl 4-amino-1,1-dioxothiane-4-carboxylate;2H-Thiopyran-4-carboxylic acid, 4-aminotetrahydro-, ethyl ester, 1,1-dioxide
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- TRC
Package
- 5MG
- 10mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM1554966
- Product descriptionETHYL-4-AMINO-1,1-DIOXOTHIANE-4-CARBOXYLATE 95.00%
- Packaging5MG
- Price$457.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11316073
- Product descriptionEthyl4-aminotetrahydro-2H-thiopyran-4-carboxylate1,1-dioxide 95+%
- Packaging1g
- Price$1058
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB437980
- Product descriptionethyl4-amino-1,1-dioxothiane-4-carboxylate
- Packaging5mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB437980
- Product descriptionethyl4-amino-1,1-dioxothiane-4-carboxylate
- Packaging10mg
- Price$90
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM1554966 | ETHYL-4-AMINO-1,1-DIOXOTHIANE-4-CARBOXYLATE 95.00% | 5MG | $457.95 | 2021-12-16 | Buy |
| Crysdot | CD11316073 | Ethyl4-aminotetrahydro-2H-thiopyran-4-carboxylate1,1-dioxide 95+% | 1g | $1058 | 2021-12-16 | Buy |
| TRC | B437980 | ethyl4-amino-1,1-dioxothiane-4-carboxylate | 5mg | $45 | 2021-12-16 | Buy |
| TRC | B437980 | ethyl4-amino-1,1-dioxothiane-4-carboxylate | 10mg | $90 | 2021-12-16 | Buy |
Properties
Boiling point :388.2±42.0 °C(Predicted)
Density :1.277±0.06 g/cm3(Predicted)
pka :5.32±0.20(Predicted)
Density :1.277±0.06 g/cm3(Predicted)
pka :5.32±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|